Skip to main content
. 2022 Feb 15;12:2552. doi: 10.1038/s41598-022-06221-8

Figure 1.

Figure 1

Consort diagram illustrating numbers of participants with moderate-severe COVID-19 randomized (1:1) to treatment with convalescent plasma or placebo.